DXB 1.49% 33.0¢ dimerix limited

Ann: Half Year Report and Update, page-79

  1. 1,918 Posts.
    lightbulb Created with Sketch. 390
    I am a bit confused by ur response ..... May be u typed in a hurry ...

    So agree with ur fact that they cannot afford to fund a P3 trial....and sooner or later they need money ...

    But what are you trying to say next? You said "someone else running a P3 trial in an indication that most are not confident in succeeding is not enough to raise SP?"

    U serious or u wanted to say something different?
    Just logically why would any one else (Pharma organisation) agree to spend millions of $ to run a trial if they don't see a decent chance of success?

    Or u trying to say they won't get a partner coz YOU think the data isn't strong enough? Now you can have that point of view but I take experts view any day especially those who are putting their names in recommending based on the detailed data they have seen for months now.
    Last edited by singhgu: 09/03/21
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
-0.005(1.49%)
Mkt cap ! $181.3M
Open High Low Value Volume
34.0¢ 34.0¢ 32.5¢ $1.121M 3.386M

Buyers (Bids)

No. Vol. Price($)
3 907553 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 195382 3
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
33.0¢
  Change
-0.005 ( 1.49 %)
Open High Low Volume
33.5¢ 34.0¢ 32.5¢ 1712129
Last updated 15.54pm 10/05/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.